$3.48 Billion is the total value of UBS OCONNOR LLC's 20 reported holdings in Q4 2012. The portfolio turnover from Q3 2012 to Q4 2012 was 500.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CVH | Buy | COVENTRY | $94,170,000,000 | +196.0% | 2,100,601 | +175.3% | 31.80% | -50.0% |
| NXY | New | NEXEN IN | $70,517,000,000 | – | 2,617,567 | +100.0% | 23.81% | – |
| S | New | SPRINT N | $57,612,000,000 | – | 10,160,780 | +100.0% | 19.46% | – |
| PXP | New | PLAINS E | $29,028,000,000 | – | 618,400 | +100.0% | 9.80% | – |
| SHS | New | SAUER-DA | $12,721,000,000 | – | 238,356 | +100.0% | 4.30% | – |
| MMR | New | MCMORAN | $11,153,000,000 | – | 694,913 | +100.0% | 3.77% | – |
| New | CLEARWIRcla | $9,229,000,000 | – | 3,193,637 | +100.0% | 3.12% | – | |
| CLWR | New | CLEARWIRcla | $9,229,000,000 | – | 3,193,637 | +100.0% | 3.12% | – |
| NYX | New | NYSE EUR | $1,763,000,000 | – | 55,908 | +100.0% | 0.60% | – |
| NXY | New | NEXEN INcall | $693,000,000 | – | 439,300 | +100.0% | 0.23% | – |
| SHAW | Exit | SHAW GRO | $0 | – | -417,307 | -100.0% | -36.39% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| META PLATF | 36 | Q3 2023 | 2.3% |
| SPDR S&P 5 | 33 | Q3 2023 | 0.7% |
| ACTIVISION | 29 | Q3 2023 | 71.3% |
| AMAZON COM | 29 | Q3 2023 | 0.8% |
| GAMING & L | 29 | Q3 2023 | 0.8% |
| SPDR S&P | 29 | Q1 2023 | 0.1% |
| DISNEY W | 28 | Q3 2021 | 2.0% |
| POST HLD | 27 | Q2 2020 | 1.8% |
| GENERAL | 27 | Q3 2022 | 1.4% |
| CAMDEN PPT | 27 | Q3 2023 | 0.6% |
View UBS OCONNOR LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| HERON THERAPEUTICS, INC. /DE/Sold out | February 13, 2023 | 0 | 0.0% |
| MAGELLAN HEALTH INCSold out | February 13, 2023 | 0 | 0.0% |
| New Providence Acquisition Corp. II | February 13, 2023 | 2,227,500 | 8.9% |
| Nuance Communications, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| SCP & CO Healthcare Acquisition CoSold out | February 13, 2023 | 0 | 0.0% |
| ACORDA THERAPEUTICS INCSold out | February 14, 2022 | 0 | 0.0% |
| Amryt Pharma plc | February 14, 2022 | 9,950,000 | 3.1% |
| Evolv Technologies Holdings, Inc. | February 14, 2022 | 1,547,311 | 1.1% |
| GreenSky, Inc. | February 14, 2022 | 698,553 | 0.8% |
| GTY Technology Holdings Inc. | February 14, 2022 | 758,000 | 1.3% |
View UBS OCONNOR LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
View UBS OCONNOR LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.